| 05/05/2026 3:05 PM | OnKure Therapeutics (1637715) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/04/2026 11:15 PM | OnKure Therapeutics (1637715) Filer | Form EFFECT | |
| 04/24/2026 3:03 PM | OnKure Therapeutics (1637715) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 04/21/2026 3:15 PM | OnKure Therapeutics (1637715) Filer | Form ARS | |
| 04/21/2026 3:15 PM | OnKure Therapeutics (1637715) Filer | Form DEF 14A | |
| 04/21/2026 3:16 PM | OnKure Therapeutics (1637715) Filer | Form DEFA14A | |
| 04/07/2026 8:14 PM | AI Biotechnology LLC (1942670) Filed by OnKure Therapeutics (1637715) Subject | Form SCHEDULE 13D | |
| 04/07/2026 8:15 PM | Access Industries Holdings LLC (1391297) Reporting ACCESS INDUSTRIES MANAGEMENT, LLC (1508226) Reporting AI Biotechnology LLC (1942670) Reporting Blavatnik Len (1326628) Reporting OnKure Therapeutics (1637715) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/07/2026 6:21 PM | OnKure Therapeutics (1637715) Subject StepStone Group LP (1502287) Filed by | Form SCHEDULE 13G | |
| 04/07/2026 3:30 PM | OnKure Therapeutics (1637715) Subject Trails Edge Capital Partners, LP (2077247) Filed by | Form SCHEDULE 13G | |
| 04/07/2026 3:13 PM | OnKure Therapeutics (1637715) Subject RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by | Form SCHEDULE 13G | |
Get the Latest News and Ratings for OKUR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for OnKure Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/03/2026 2:29 PM | OnKure Therapeutics (1637715) Issuer Saccomano Nicholas A (1609284) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 2:25 PM | Agresta Samuel (1748961) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 2:26 PM | Hartley Dylan (2037442) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 2:27 PM | Leverone Jason A. (1692747) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 4:25 PM | OnKure Therapeutics (1637715) Issuer Ratcliffe Liam (1547100) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 4:24 PM | OnKure Therapeutics (1637715) Issuer Ratcliffe Liam (1547100) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 10:17 AM | ACORN BIOVENTURES, L.P. (1766853) Filed by OnKure Therapeutics (1637715) Subject | Form SCHEDULE 13G | |
| 03/30/2026 5:01 AM | OnKure Therapeutics (1637715) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/24/2026 5:56 PM | Leverone Jason A. (1692747) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 5:57 PM | OnKure Therapeutics (1637715) Issuer Saccomano Nicholas A (1609284) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 7:15 PM | ADAR1 Capital Management, LLC (1940272) Filed by OnKure Therapeutics (1637715) Subject | Form SCHEDULE 13G | |
| 01/02/2026 3:16 PM | Mathers Edward T (1328625) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:10 PM | Manke Isaac (1622769) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 7:08 PM | Leverone Jason A. (1692747) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 7:09 PM | OnKure Therapeutics (1637715) Issuer Saccomano Nicholas A (1609284) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 7:15 AM | OnKure Therapeutics (1637715) Subject Prosight Management, LP (1617201) Filed by | Form SCHEDULE 13G | |
| 11/21/2025 3:09 PM | OnKure Therapeutics (1637715) Filer | Form 424B3 | |
| 11/18/2025 11:15 PM | OnKure Therapeutics (1637715) Filer | Form EFFECT | |
| 11/06/2025 4:25 PM | OnKure Therapeutics (1637715) Filer | Form POS AM | |
| 11/06/2025 4:08 PM | OnKure Therapeutics (1637715) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/06/2025 3:13 PM | OnKure Therapeutics (1637715) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/02/2025 3:29 PM | Mathers Edward T (1328625) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 6:41 PM | Leverone Jason A. (1692747) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 6:42 PM | OnKure Therapeutics (1637715) Issuer Saccomano Nicholas A (1609284) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2025 4:28 PM | OnKure Therapeutics (1637715) Subject Samsara BioCapital, L.P. (1699737) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2025 4:20 PM | OnKure Therapeutics (1637715) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2025 3:09 PM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (919185) Filed by OnKure Therapeutics (1637715) Subject | Form SCHEDULE 13G | |
| 08/12/2025 3:20 PM | OnKure Therapeutics (1637715) Filer | Form 424B3 | |
| 08/12/2025 3:20 PM | OnKure Therapeutics (1637715) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2025 3:20 PM | OnKure Therapeutics (1637715) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
| 07/02/2025 3:33 PM | Mathers Edward T (1328625) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2025 3:16 PM | OnKure Therapeutics (1637715) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2025 5:52 PM | OnKure Therapeutics (1637715) Issuer Saccomano Nicholas A (1609284) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 5:49 PM | Leverone Jason A. (1692747) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/30/2025 4:05 PM | Mathers Edward T (1328625) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/30/2025 2:57 PM | ACORN BIOVENTURES, L.P. (1766853) Filed by OnKure Therapeutics (1637715) Subject | Form SCHEDULE 13D/A | |
| 05/29/2025 3:33 PM | OnKure Therapeutics (1637715) Subject Shay Capital LLC (1723643) Filed by | Form SCHEDULE 13G | |
| 05/28/2025 3:30 PM | OnKure Therapeutics (1637715) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2025 6:44 PM | ACORN BIOVENTURES 2, L.P. (1876405) Reporting Acorn Capital Advisors GP 2, LLC (2070458) Reporting OnKure Therapeutics (1637715) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/19/2025 4:33 PM | Chen Bihua (1599214) Reporting Cormorant Asset Management, LP (1583977) Reporting Cormorant Global Healthcare Master Fund, LP (1618442) Reporting Cormorant Private Healthcare Fund III LP (1817320) Reporting Cormorant Private Healthcare Fund IV LP (1871297) Reporting Cormorant Private Healthcare Fund V LP (1969296) Reporting OnKure Therapeutics (1637715) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2025 2:02 PM | Cormorant Asset Management, LP (1583977) Filed by OnKure Therapeutics (1637715) Subject | Form SCHEDULE 13G/A | |
| 05/06/2025 6:35 AM | OnKure Therapeutics (1637715) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2025 6:40 AM | OnKure Therapeutics (1637715) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/06/2025 6:45 AM | OnKure Therapeutics (1637715) Filer | Form 424B3 | |